NPCUF — Allon Therapeutics Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- -$0.41m
Annual cashflow statement for Allon Therapeutics, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | C2010 December 31st | 2011 December 31st | 2012 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -11.3 | -7.34 | -16.1 | -12.8 | -14.9 |
Depreciation | |||||
Non-Cash Items | 0.371 | 0.358 | 0.2 | 0.254 | 4.43 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.05 | -1.63 | 2.27 | 0.349 | 0.72 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -12.4 | -8.07 | -13.1 | -11.6 | -9.27 |
Capital Expenditures | -0.025 | -0.023 | -0.013 | -0.008 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1.12 | 0 | 0.038 | 0 | — |
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 1.09 | -0.023 | 0.024 | -0.008 | 0 |
Financing Cash Flow Items | — | — | — | — | 9.42 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 18.4 | 0 | 9.91 | 4.92 | 9.52 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7.08 | -8.09 | -3.14 | -6.74 | 0.25 |